NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

Why Doximity Stock Is Soaring After Hours

Published 10/11/2022, 22:01
Updated 10/11/2022, 23:10
© Reuters.  Why Doximity Stock Is Soaring After Hours
DOCS
-

Benzinga - Doximity Inc (NYSE: DOCS) shares are trading higher in Thursday's after-hours session after the company reported better-than-expected financial results.

Doximity said fiscal second-quarter revenues climbed 29% year-over-year to $102.19 million, which beat average analyst estimates of $100.12 million, according to Benzinga Pro. The company reported quarterly earnings of 17 cents per share, which beat average analyst estimates of 15 cents per share.

Doximity said its telehealth platform grew to 370,000 active clinicians during the second quarter.

Doximity expects fiscal third-quarter revenue to be between $110.7 million and $111.7 million versus average analyst estimates of $114.88 million. The company reiterated that it expects full-year 2022 revenue to be in a range of $424 million to $432 million versus average analyst estimates of $426.36 million.

Doximity's board also authorized a buyback of up to $70 million of the company's common stock.

Doximity operates the leading digital platform for U.S. medical professionals.

DOCS Price Action: Doximity has a 52-week high of $64.95 and a 52-week low of $22.91.

The stock was up 19.8% in after hours at $31.55 at time of publication.

Photo: courtesy of Doximity.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.